{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:08:35Z","timestamp":1795036115563,"version":"4.10.2"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Pneumococcal conjugate vaccines (<jats:styled-content style=\"fixed-case\">PCV<\/jats:styled-content>s) are highly effective in preventing invasive pneumococcal diseases (<jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content>) in children, including those with sickle cell disease (<jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content>). A systematic review of the English literature published between 2000 and 2017 was undertaken to evaluate the serotype distribution, clinical presentation and outcomes of <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content> in children with <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">PCV<\/jats:styled-content> programmes. We identified 475 potential studies and included 16 publications, involving 9438 children up to 22\u00a0years of age with <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content> and 182 <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content> episodes (prevalence, 1\u00b79%. 95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>], 1\u00b77\u20132\u00b72%). Septicaemia was the most prevalent clinical presentation (84\/137; 61%) followed by lower respiratory tract infection (39\/137; 29%) and meningitis (12\/137, 9%). More than half the serotypes associated with <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content> (88\/148; 59\u00b75%) were not included in the 13\u2010valent <jats:styled-content style=\"fixed-case\">PCV<\/jats:styled-content>; of these, 54% (44\/82) were due to serogroup 15. The crude case fatality rate was 11\u00b75% (21\/182 cases; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 7\u00b73\u201317\u00b71%). Most cases of <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content> in children with <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content> were due to serotypes that are not included in any of the licensed <jats:styled-content style=\"fixed-case\">PCV<\/jats:styled-content>s. <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content> in children with <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content> remains associated with high morbidity and mortality, highlighting the importance of strict adherence to daily penicillin prophylaxis. Until a serotype\u2010independent pneumococcal vaccine becomes available, higher\u2010valent <jats:styled-content style=\"fixed-case\">PCV<\/jats:styled-content>s should include serogroup 15 to protect this highly vulnerable group of children.<\/jats:p>","DOI":"10.1111\/bjh.15846","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T03:55:21Z","timestamp":1552362921000},"page":"743-751","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature"],"prefix":"10.1111","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-3969","authenticated-orcid":false,"given":"Godwin","family":"Oligbu","sequence":"first","affiliation":[{"name":"Paediatric Infectious Diseases Research Group Institute for Infection and Immunity St.\u00a0George's, University of London London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fallaha","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Imperial College London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Pay","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Imperial College London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez","family":"Ladhani","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Research Group Institute for Infection and Immunity St.\u00a0George's, University of London London UK"},{"name":"Immunisation and Countermeasures Division Public Health England London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00331-7"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0018"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2139"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22461"},{"key":"e_1_2_10_6_1","first-page":"141","article-title":"Sickle cell anemia and functional asplenia (author's transl)","volume":"39","author":"Beauvais P.","year":"1982","journal-title":"Archives Francaises de Pediatrie"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00730.x"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200003000-00003"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283531b0f"},{"key":"e_1_2_10_10_1","first-page":"3","article-title":"Prevalence and Etiology of Bacteremia in Febrile Children with Sickle Cell Disease at a Nigeria Tertiary Hospital","volume":"9","author":"Brown B.","year":"2017","journal-title":"Mediterranean Journal of Haematology and Infectious Diseases"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.04.005"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e31828ac9e2"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000078"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14015"},{"key":"e_1_2_10_15_1","first-page":"CD003885","article-title":"Pneumococcal vaccines for sickle cell disease","volume":"1","author":"Davies E.G.","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318286c75b"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606193142501"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/516781"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200208000-00012"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ371"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26713"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.11.025"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23259"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318240d50d"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000858"},{"key":"e_1_2_10_27_1","first-page":"643","article-title":"Risk of invasive pneumococcal disease in children with sickle cell disease in england: a National Observational Cohort Study, 2010\u20132015","volume":"103","author":"Oligbu G.","year":"2018","journal-title":"Archives of Disease in Childhood"},{"key":"e_1_2_10_28_1","first-page":"784","article-title":"Bacterial meningitis and septicemia in sickle cell disease","volume":"131","author":"Overturf G.D.","year":"1977","journal-title":"American Journal of Diseases of Children"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2013.786157"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182a11808"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/136.Supplement.S25"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70055-4"},{"key":"e_1_2_10_33_1","first-page":"CD003427","article-title":"Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease","volume":"10","author":"Rankine\u2010Mullings A.E.","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2009.04.002"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2014.06.025"},{"key":"e_1_2_10_36_1","first-page":"e5512","article-title":"Invasive bacterial infections in Gambians with sickle cell anemia in an era of widespread pneumococcal and hemophilus influenzae type b vaccination","volume":"95","author":"Soothill G.","year":"2016","journal-title":"Medicine (United States)"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17192-4"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.10517"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.15846","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15846","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.15846","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T12:39:03Z","timestamp":1694349543000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.15846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1111\/bjh.15846"],"URL":"https:\/\/doi.org\/10.1111\/bjh.15846","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"2018-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}